
Invested in plant-derived raw materials that are expected to reduce CO2 emissions by up to 50%.
On September 29, 2022, Kao Corporation joined leading sustainable materials companies Geno and Unilever as a founding member of a venture company that aims to commercialize plant-derived raw materials to replace those derived from palm oil. The company has made an additional investment of US$120 million (approximately 17 billion yen), which has already been announced by Geno and Unilever.
This venture will stabilize and strengthen the supply chain in the $652 billion global home and personal care market as demand for sustainably sourced palm oil increases worldwide, and will provide socially and environmentally responsible and responsibly sourced palm oil alternatives to the market. Geno's technology is also designed to provide a socially and environmentally responsible alternative to fossil-based palm oil. Geno's technology will also provide an alternative to fossil-based raw materials.
Initial studies indicate that alternative plant-derived raw materials based on Geno's technology are expected to reduce CO2 emissions by up to 50% compared to raw materials derived from palm oil.
With Kao's investment, the venture will further expand its capacity to produce an alternative palm oil feedstock. This is a very important step toward achieving Geno's goal of reducing greenhouse gas emissions by 100 million tons over the next several years.
The addition of Kao's expertise in the Consumer Products and Chemicals businesses, developed over more than 130 years, is expected to further strengthen the global reach and influence of this venture.
Kao has set a goal of zero carbon by 2040 and carbon negative by 2050, and this initiative is an important strategic decision to achieve that goal.
As sustainable palm oil and its derivatives continue to be a critical raw material for Kao, this venture will use biotechnology to produce more sustainable palm oil substitutes that Kao will use in its home and personal care products, as well as supply its derivatives to its chemical business customers. Kao will use them in its home and personal care products and supply derivatives to its chemical business customers.
We will also further promote responsible raw material procurement by establishing a new supply chain that is traceable and transparent.
Christophe Schilling, CEO of Geno, stated.
Geno has been working with leading global brands and value chain partners to provide sustainable solutions for traceable and responsible sourcing of raw materials at commercial scale, and we are excited to have Kao as a founding member of our palm oil substitution venture with Unilever. Geno has been collaborating with leading global brands and value chain partners to provide sustainable solutions for traceable and responsible raw material sourcing at commercial scale. Kao's participation in this venture is another example of the collaboration that Geno has been pursuing. Together, we will stabilize and strengthen the supply chains that people and the planet need today and for the future. With Kao's deep knowledge of the home and personal care market, we can help manufacturers (in the supply chain) achieve their sustainability commitments and meet the growing consumer demand for sustainable products."
Mr. Masahiro Katayose, Senior Executive Officer and General Manager of the Chemical Business Division of Kao Corporation, stated, "Kao has been working to develop a new business model for the chemical industry.
We are very pleased to be investing in this wonderful, cutting-edge biotech venture. Kao is a manufacturer of consumer products for household use and a chemical manufacturer that provides a variety of materials to industry. Geno's biotechnology is indispensable for the diversification of sustainable raw material procurement, and we will continue to procure palm oil responsibly and sustainably in order to contribute to the sustainable development and recycling of society. Our investment in this venture will enable us to provide new eco-chemical solutions and provide an opportunity for Kao to play a greater role in helping consumers, customers, industry, and society realize the shift toward a decarbonized and circular economy."
About Geno
Geno (headquartered in San Diego, California, USA) uses biotechnology to transform a wide range of fossil-based products and chemicals into more environmentally friendly products.
In response to the impending climate change crisis, Geno has spent the past two decades developing and scaling up sustainable raw materials made from plants and waste instead of fossil raw materials. geno's technology has enabled us to replace raw materials and materials used in cosmetics, carpets, home cleaners, apparel, and more with more sustainable alternatives. Geno's technology is replacing raw materials and materials used in cosmetics, carpets, home cleaners, apparel, and more with more sustainable alternatives.
Over the past several years, Geno has collaborated with lululemon to provide plant-based products, partnered with Aquafil to reach a production milestone for plant-based nylon, partnered with Covestro to reach a production milestone for plant-based HMD We have been implementing high-impact collaborations to accelerate the global deployment and commercialization of sustainable materials, including a partnership with lululemon to achieve a production milestone for plant-based nylon, a partnership with Aquafil to achieve a production milestone for plant-based nylon, and a partnership with Asahi Kasei to explore the practical application of plant-based nylon 66. For more information,genomatica.comfor more information.
*This information is the same information that was sent out by Geno on September 29 in the United States.
PDF
https://prtimes.jp/a/?f=d70897-20220928-24f3a7be12f2c67ea741208348bcc5a5.pdf
News Release URL
https://www.kao.com/jp/corporate/news/business-finance/2022/20220929-001/









